
Adam Stuart Kibel MD
Professor of Surgery, Harvard University, Cambridge, Massachusetts; Chief of Urology, Brigham and Women’s Hospital/Dana-Farber Cancer Institute, Boston, MassachusettsDr. Kibel is a Professor of Surgery at Harvard University, the Chief of Urology at Brigham and Women’s Hospital /Dana Farber Cancer Institute and Chairman of the Harvard Residency Program (Longwood). He is Co-Director of the DFCI/Harvard Cancer Center Prostate Cancer Program.
Disclosures
- Serve(d) on Ad boards for Dendreon and Sanofi Aventis
Recent Contributions to PracticeUpdate:
- Salvage vs Adjuvant Therapy in High-Risk Prostate Cancer
- Optimizing Staging in Bladder Cancer
- Neoadjuvant Therapy for Locally Advanced Prostate Cancer
- Degarelix in Prolonging the Off-Treatment Interval in Men With Localized Prostate Cancer Receiving Intermittent ADT for Biochemical Recurrence Following Radical Local Therapy
- A Systematic Review and Framework for the Use of Hormone Therapy With Salvage Radiation Therapy for Recurrent Prostate Cancer
- When All Is Said and Done, Screening Decreases Prostate Cancer Mortality: ERSPC and PLCO Trials
- Functional Outcome Results From Radical Prostatectomy After Several Prostate Biopsies
- A Randomized Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinizing Hormone–Releasing Hormone Agonists vs Transdermal Estradiol
- EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer